MEDINET Co., Ltd. AI Stock Analysis
Want to see JP:2370 full AI Analyst Report?
MEDINET Co., Ltd. (2370) AI Stock Analysis
MEDINET Co., Ltd.
(TSE/TYO:2370)
MEDINET Co., Ltd. receives a very low score primarily driven by severe operational cash burn and a firmly entrenched bearish technical downtrend. While the company maintains a zero-debt balance sheet that provides a minor safety net, staggering net losses and rapid equity erosion pose substantial long-term risks. Furthermore, negative earnings multiples highlight its highly speculative nature, with current technical indicators offering no signs of an impending momentum reversal.
MEDINET Co., Ltd. (2370) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 4.55B
- Dividend Yield
- ―
- Average Volume (3M)
- 606.30K
- Price to Earnings (P/E)
- -3.1
- Beta (1Y)
- 0.71
- Revenue Growth
- 1.41%
- EPS Growth
- 1.12%
- Country
- Japan
- Employees
- 107
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
MEDINET Co., Ltd. Business Overview & Revenue Model
Company Description
Established in 1995 and headquartered in Tokyo, Japan, MEDINET Co., Ltd. functions as a contract development and manufacturing organization (CDMO) primarily focused on regenerative medicine and cell therapy solutions within Japan. The company furnish...
MEDINET Co., Ltd. Financial Statement Overview
Summary
Despite a pristine zero-debt balance sheet, the company faces severe structural cash burn, massive net losses with a -170% net profit margin, and rapidly declining stockholder equity, posing significant viability risks.
Income Statement
25NegativeBalance Sheet
55NeutralCash Flow
20Very Negative| Breakdown | TTM | Sep 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 724.63M | 821.73M | 810.29M | 768.50M | 661.54M | 633.67M |
| Gross Profit | 128.40M | 151.01M | 83.44M | 82.67M | 65.21M | 90.44M |
| EBITDA | -1.29B | -1.42B | -1.26B | -1.20B | -1.36B | -1.17B |
| Net Income | -1.41B | -1.40B | -1.36B | -1.28B | -1.44B | -1.25B |
Balance Sheet | ||||||
| Total Assets | 6.35B | 3.58B | 4.25B | 5.70B | 5.63B | 6.08B |
| Cash, Cash Equivalents and Short-Term Investments | 5.03B | 2.42B | 3.17B | 4.65B | 4.40B | 4.50B |
| Total Debt | 91.32M | 0 | 0 | 781.00K | 2.31M | 4.30M |
| Total Liabilities | 548.63M | 672.01M | 477.10M | 509.95M | 590.60M | 566.58M |
| Stockholders Equity | 5.80B | 2.91B | 3.78B | 5.19B | 5.04B | 5.51B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -1.35B | -1.44B | -1.25B | -1.28B | -1.14B |
| Operating Cash Flow | 0 | -1.33B | -1.41B | -1.19B | -1.26B | -1.13B |
| Investing Cash Flow | 0 | 553.80M | -565.17M | -12.71M | -2.16M | -50.35M |
| Financing Cash Flow | 0 | 532.79M | -2.55M | 1.46B | 1.16B | 1.58B |
MEDINET Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2370, the sentiment is Negative. The current price of 16.00 is below the 20-day moving average (MA) of 19.25, below the 50-day MA of 22.08, and below the 200-day MA of 26.33, indicating a bearish trend. The MACD of -1.66 indicates Positive momentum. The RSI at 26.57 is Positive, neither overbought nor oversold. The STOCH value of 27.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2370.
MEDINET Co., Ltd. Peers Comparison
Overall Rating
JP:238567Neutral
JP:218350Neutral
JP:234244Neutral
JP:237039Underperform
JP:206A37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 67Neutral | JPY 5.49B | 32.41 | ― | 4.76% | -33.44% | 3.65% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 50Neutral | JPY 4.45B | -1.23 | ― | 4.06% | -23.55% | -205.65% | |
| 44Neutral | JPY 3.07B | -165.15 | ― | ― | 8.53% | 97.93% | |
| 39Underperform | JPY 4.55B | -3.14 | ― | ― | 1.41% | 1.12% | |
| 37Underperform | JPY 3.11B | -2.62 | ― | ― | -23.40% | -40.15% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:2370 | MEDINET Co., Ltd. | 16.00 | -15.00 | -48.39% | |
| JP:2183 | Linical Co., Ltd. | 197.00 | -94.98 | -32.53% | |
| JP:2342 | Trans Genic Inc. | 182.00 | -44.00 | -19.47% | |
| JP:2385 | Soiken Holdings Inc. | 210.00 | -5.82 | -2.69% | |
| JP:206A | PRISM BioLab Co. LTD | 84.00 | -86.00 | -50.59% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 16, 2026
